Diabetic Myonecrosis in a Cystic Fibrosis Patient

References

1. 1.↵
   1. Moran A,
   2. Dunitz J,
   3. Nathan B,
   4. Saeed A,
   5. Holme B,
   6. Thomas W

   . Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009;32(9):1626–1631.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Angervall LSB

   . Tumoriform focal muscular degeneration in two diabetic patients. Diabetologia 1965;1:39–42.

   OpenUrlCrossRef
3. 3.↵
   1. Rocca PV,
   2. Alloway JA,
   3. Nashel DJ

   . Diabetic muscular infarction. Semin Arthritis Rheum 1993;22(4):280–287.

   OpenUrlPubMedWeb of Science
4. 4.↵
   1. Trujillo-Santos AJ

   . Diabetic muscle infarction: an underdiagnosed complication of long-standing diabetes. Diabetes Care 2003;26(1):211–215.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Palmer GW,
   2. Greco TP

   . Diabetic thigh muscle infarction in association with antiphospholipid antibodies. Semin Arthritis Rheum 2001;30(4):272–280.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Jelinek JS,
   2. Murphey MD,
   3. Aboulafia AJ,
   4. Dussault RG,
   5. Kaplan PA,
   6. Snearly WN

   . Muscle infarction in patients with diabetes mellitus: MR imaging findings. Radiology 1999;211(1):241–247.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Nagdev A,
   2. Murphy M,
   3. Sisson C

   . Bedside ultrasound for the detection of diabetic myonecrosis. Am J Emerg Med 2008;26(8):969 e963–964.

   OpenUrl
8. 8.↵
   1. Jelinek J,
   2. Kransdorf MJ

   . MR imaging of soft-tissue masses. Mass-like lesions that simulate neoplasms. Magn Reson Imaging Clin N Am 1995;3(4):727–741.

   OpenUrlPubMed
9. 9.↵
   1. Chester CS,
   2. Banker BQ

   . Focal infarction of muscle in diabetics. Diabetes Care 1986;9(6):623–630.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Bjornskov EK,
    2. Carry MR,
    3. Katz FH,
    4. Lefkowitz J,
    5. Ringel SP

    . Diabetic muscle infarction: a new perspective on pathogenesis and management. Neuromuscul Disord 1995;5(1):39–45.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Milla CE,
    2. Billings J,
    3. Moran A

    . Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28(9):2141–2144.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Schwarzenberg SJ,
    2. Thomas W,
    3. Olsen TW,
    4. Grover T,
    5. Walk D,
    6. Milla C,
    7. et al

    . Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007;30(5):1056–1061.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Andersen HU,
    2. Lanng S,
    3. Pressler T,
    4. Laugesen CS,
    5. Mathiesen ER

    . Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 2006;29(12):2660–2663.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Moran A,
    2. Brunzell C,
    3. Cohen RC,
    4. Katz M,
    5. Marshall BC,
    6. Onady G,
    7. et al

    . Clinical care guidelines for cystic fibrosis-related diabetes. A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33(12):2697–2708.

    OpenUrlFREE Full Text
15. 15.↵
    1. van den Berg JM,
    2. Morton AM,
    3. Kok SW,
    4. Pijl H,
    5. Conway SP,
    6. Heijerman HG

    . Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD). J Cyst Fibros 2008;7(6):515–519.

    OpenUrlCrossRefPubMed